BIOMAT Database Logo BIOMAT Database Logo

Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder. 2017

Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
1 Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Small leucine-rich proteoglycans are components of extracellular matrix that regulates neoplastic transformation. Among small leucine rich proteoglycans, Decorin, Biglycan and Lumican are most commonly implicated markers, and their expression is well studied in various malignancies. In this novel study, we have collectively evaluated expression of these three molecules in urothelial carcinoma of bladder. Thirty patients of confirmed untreated bladder cancer, 30 healthy controls for blood and 30 controls for adjacent non-tumour tissue were enrolled. Blood was collected from all subjects and tumour/adjacent normal tissue was obtained from the patients. Circulatory levels were estimated by enzyme-linked immunosorbent assay, relative messenger RNA expression by quantitative polymerase chain reaction and protein expression by immunohistochemistry and western-blotting. Circulatory levels of Biglycan (p = 0.0038) and Lumican (p < 0.0001) were significantly elevated, and that of Decorin (p < 0.0001) was significantly reduced in patients as compared with controls. Protein expression by immunohistochemistry and western-blotting showed elevated expression of Lumican and Biglycan and lower expression of Decorin in urothelial carcinoma of bladder. Quantitative polymerase chain reaction for messenger RNA expression from tissue specimens revealed significantly higher expression of Biglycan (p = 0.0008) and Lumican (p = 0.01) and lower expression of Decorin (p < 0.0001) in urothelial carcinoma of bladder. Out of all molecules receiver operating characteristic curve showed that the 0.207 ng/ml cut-off of serum Lumican provided optimum sensitivity (90.0%) and specificity (90.0%). Significant alteration of matrix small leucine-rich proteoglycans in urothelial carcinoma of bladder was observed. Higher expression of Lumican in Bladder cancer patients with the cut-off value of highest optimum sensitivity and specificity shows its importance as a potential non-invasive marker for early detection of UBC following further validation in large patient cohort.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071234 Lumican A small leucine-rich proteoglycan that contains 10 tandem leucine repeats and four N-linked sites within the leucine repeat region that may be substituted with KERATAN SULFATE. These properties and its horseshoe shape allow it to mediate interactions among COLLAGEN molecules within fibrils. It is expressed in most mesenchymal tissues as well as the CORNEA, where it functions to maintain transparency. Lumican Proteoglycan
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic

Related Publications

Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
March 2018, Clinical oral investigations,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans--biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin.
February 2000, Proteins,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican.
October 2000, Kidney international,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases.
September 2021, International journal of molecular sciences,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan.
August 2006, Biomacromolecules,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin.
August 2011, Cell proliferation,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
[Differential expression of small leucine-rich proteoglycans gene in Lumican transgenic mouse cornea].
December 2018, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin.
March 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.
January 2003, Clinical cancer research : an official journal of the American Association for Cancer Research,
Sandeep Appunni, and Vivek Anand, and Madhuram Khandelwal, and Amlesh Seth, and Sandeep Mathur, and Alpana Sharma
Targeted disruption of two small leucine-rich proteoglycans, biglycan and decorin, excerpts divergent effects on enamel and dentin formation.
November 2005, Calcified tissue international,
Copied contents to your clipboard!